$CBLI Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in CLEVELAND BIOLABS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in CLEVELAND BIOLABS INC. Get notifications about new insider transactions in CLEVELAND BIOLABS INC for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 04 2010 | CBLI | CLEVELAND BIOLABS ... | Kogan Yakov | COO, Secretary | Sell | S | 3.79 | 400 | 1,516 | 661,400 | 661.8 K to 661.4 K (-0.06 %) |
May 04 2010 | CBLI | CLEVELAND BIOLABS ... | Kogan Yakov | COO, Secretary | Sell | S | 3.77 | 600 | 2,262 | 661,800 | 662.4 K to 661.8 K (-0.09 %) |
May 04 2010 | CBLI | CLEVELAND BIOLABS ... | Kogan Yakov | COO, Secretary | Sell | S | 3.80 | 100 | 380 | 662,400 | 662.5 K to 662.4 K (-0.02 %) |
May 04 2010 | CBLI | CLEVELAND BIOLABS ... | Kogan Yakov | COO, Secretary | Sell | S | 3.77 | 100 | 377 | 662,500 | 662.6 K to 662.5 K (-0.02 %) |
May 04 2010 | CBLI | CLEVELAND BIOLABS ... | Kogan Yakov | COO, Secretary | Sell | S | 3.75 | 2,600 | 9,750 | 662,600 | 665.2 K to 662.6 K (-0.39 %) |
May 04 2010 | CBLI | CLEVELAND BIOLABS ... | Kogan Yakov | COO, Secretary | Sell | S | 3.76 | 500 | 1,880 | 665,200 | 665.7 K to 665.2 K (-0.08 %) |
May 04 2010 | CBLI | CLEVELAND BIOLABS ... | Kogan Yakov | COO, Secretary | Sell | S | 3.73 | 100 | 373 | 665,700 | 665.8 K to 665.7 K (-0.02 %) |
May 04 2010 | CBLI | CLEVELAND BIOLABS ... | Kogan Yakov | COO, Secretary | Sell | S | 3.70 | 300 | 1,110 | 665,800 | 666.1 K to 665.8 K (-0.05 %) |
May 04 2010 | CBLI | CLEVELAND BIOLABS ... | Kogan Yakov | COO, Secretary | Sell | S | 3.72 | 375 | 1,395 | 666,100 | 666.5 K to 666.1 K (-0.06 %) |
May 04 2010 | CBLI | CLEVELAND BIOLABS ... | Kogan Yakov | COO, Secretary | Sell | S | 3.78 | 425 | 1,607 | 666,475 | 666.9 K to 666.5 K (-0.06 %) |
May 04 2010 | CBLI | CLEVELAND BIOLABS ... | Kogan Yakov | COO, Secretary | Sell | S | 3.81 | 200 | 762 | 666,900 | 667.1 K to 666.9 K (-0.03 %) |
May 04 2010 | CBLI | CLEVELAND BIOLABS ... | Kogan Yakov | COO, Secretary | Sell | S | 3.83 | 100 | 383 | 667,100 | 667.2 K to 667.1 K (-0.01 %) |
Apr 20 2010 | CBLI | CLEVELAND BIOLABS ... | Kogan Yakov | COO, Secretary | Option Exercise | A | 3.79 | 30,000 | 113,700 | 30,000 | |
Apr 19 2010 | CBLI | CLEVELAND BIOLABS ... | Gudkov Andrei V | Chief Scientific Of ... | Sell | S | 3.61 | 3,900 | 14,079 | 1,509,600 | 1.5 M to 1.5 M (-0.26 %) |
Apr 19 2010 | CBLI | CLEVELAND BIOLABS ... | Gudkov Andrei V | Chief Scientific Of ... | Sell | S | 3.60 | 800 | 2,880 | 1,513,500 | 1.5 M to 1.5 M (-0.05 %) |
Apr 19 2010 | CBLI | CLEVELAND BIOLABS ... | Gudkov Andrei V | Chief Scientific Of ... | Sell | S | 3.62 | 100 | 362 | 1,514,300 | 1.5 M to 1.5 M (-0.01 %) |
Apr 19 2010 | CBLI | CLEVELAND BIOLABS ... | Gudkov Andrei V | Chief Scientific Of ... | Sell | S | 3.59 | 200 | 718 | 1,514,400 | 1.5 M to 1.5 M (-0.01 %) |
Apr 05 2010 | CBLI | CLEVELAND BIOLABS ... | Kogan Yakov | COO, Secretary | Sell | S | 3.51 | 300 | 1,053 | 667,200 | 667.5 K to 667.2 K (-0.04 %) |
Apr 05 2010 | CBLI | CLEVELAND BIOLABS ... | Kogan Yakov | COO, Secretary | Sell | S | 3.51 | 37 | 130 | 667,500 | 667.5 K to 667.5 K (-0.01 %) |
Apr 05 2010 | CBLI | CLEVELAND BIOLABS ... | Kogan Yakov | COO, Secretary | Sell | S | 3.51 | 1,700 | 5,967 | 667,537 | 669.2 K to 667.5 K (-0.25 %) |
Apr 05 2010 | CBLI | CLEVELAND BIOLABS ... | Kogan Yakov | COO, Secretary | Sell | S | 3.52 | 200 | 704 | 669,237 | 669.4 K to 669.2 K (-0.03 %) |
Apr 05 2010 | CBLI | CLEVELAND BIOLABS ... | Kogan Yakov | COO, Secretary | Sell | S | 3.51 | 100 | 351 | 669,437 | 669.5 K to 669.4 K (-0.01 %) |
Apr 05 2010 | CBLI | CLEVELAND BIOLABS ... | Kogan Yakov | COO, Secretary | Sell | S | 3.52 | 600 | 2,112 | 669,537 | 670.1 K to 669.5 K (-0.09 %) |
Apr 05 2010 | CBLI | CLEVELAND BIOLABS ... | Kogan Yakov | COO, Secretary | Sell | S | 3.52 | 400 | 1,408 | 670,137 | 670.5 K to 670.1 K (-0.06 %) |
Apr 05 2010 | CBLI | CLEVELAND BIOLABS ... | Kogan Yakov | COO, Secretary | Sell | S | 3.52 | 263 | 926 | 670,537 | 670.8 K to 670.5 K (-0.04 %) |
Apr 05 2010 | CBLI | CLEVELAND BIOLABS ... | Kogan Yakov | COO, Secretary | Sell | S | 3.52 | 100 | 352 | 670,800 | 670.9 K to 670.8 K (-0.01 %) |
Apr 05 2010 | CBLI | CLEVELAND BIOLABS ... | Kogan Yakov | COO, Secretary | Sell | S | 3.52 | 400 | 1,408 | 670,900 | 671.3 K to 670.9 K (-0.06 %) |
Apr 05 2010 | CBLI | CLEVELAND BIOLABS ... | Kogan Yakov | COO, Secretary | Sell | S | 3.52 | 100 | 352 | 671,300 | 671.4 K to 671.3 K (-0.01 %) |
Apr 05 2010 | CBLI | CLEVELAND BIOLABS ... | Kogan Yakov | COO, Secretary | Sell | S | 3.52 | 400 | 1,408 | 671,400 | 671.8 K to 671.4 K (-0.06 %) |
Apr 05 2010 | CBLI | CLEVELAND BIOLABS ... | Kogan Yakov | COO, Secretary | Sell | S | 3.52 | 100 | 352 | 671,800 | 671.9 K to 671.8 K (-0.01 %) |
Apr 05 2010 | CBLI | CLEVELAND BIOLABS ... | Kogan Yakov | COO, Secretary | Sell | S | 3.51 | 100 | 351 | 671,900 | 672 K to 671.9 K (-0.01 %) |
Apr 05 2010 | CBLI | CLEVELAND BIOLABS ... | Kogan Yakov | COO, Secretary | Sell | S | 3.51 | 200 | 702 | 672,000 | 672.2 K to 672 K (-0.03 %) |
Apr 05 2010 | CBLI | CLEVELAND BIOLABS ... | Kogan Yakov | COO, Secretary | Sell | S | 3.51 | 200 | 702 | 672,200 | 672.4 K to 672.2 K (-0.03 %) |
Apr 05 2010 | CBLI | CLEVELAND BIOLABS ... | Kogan Yakov | COO, Secretary | Sell | S | 3.51 | 200 | 702 | 672,400 | 672.6 K to 672.4 K (-0.03 %) |
Apr 05 2010 | CBLI | CLEVELAND BIOLABS ... | Kogan Yakov | COO, Secretary | Sell | S | 3.52 | 100 | 352 | 672,600 | 672.7 K to 672.6 K (-0.01 %) |
Apr 05 2010 | CBLI | CLEVELAND BIOLABS ... | Kogan Yakov | COO, Secretary | Sell | S | 3.50 | 100 | 350 | 672,700 | 672.8 K to 672.7 K (-0.01 %) |
Apr 05 2010 | CBLI | CLEVELAND BIOLABS ... | Kogan Yakov | COO, Secretary | Sell | S | 3.50 | 100 | 350 | 672,800 | 672.9 K to 672.8 K (-0.01 %) |
Apr 05 2010 | CBLI | CLEVELAND BIOLABS ... | Kogan Yakov | COO, Secretary | Sell | S | 3.51 | 200 | 702 | 672,900 | 673.1 K to 672.9 K (-0.03 %) |
Apr 05 2010 | CBLI | CLEVELAND BIOLABS ... | Kogan Yakov | COO, Secretary | Sell | S | 3.51 | 100 | 351 | 673,100 | 673.2 K to 673.1 K (-0.01 %) |
Mar 23 2010 | CBLI | CLEVELAND BIOLABS ... | Fonstein Michael | CEO, President | Sell | S | 3.57 | 1,400 | 4,998 | 1,271,200 | 1.3 M to 1.3 M (-0.11 %) |
Mar 23 2010 | CBLI | CLEVELAND BIOLABS ... | Fonstein Michael | CEO, President | Sell | S | 3.58 | 2,334 | 8,356 | 1,272,600 | 1.3 M to 1.3 M (-0.18 %) |
Mar 23 2010 | CBLI | CLEVELAND BIOLABS ... | Fonstein Michael | CEO, President | Sell | S | 3.59 | 300 | 1,077 | 1,274,934 | 1.3 M to 1.3 M (-0.02 %) |
Mar 23 2010 | CBLI | CLEVELAND BIOLABS ... | Fonstein Michael | CEO, President | Sell | S | 3.55 | 666 | 2,364 | 1,275,234 | 1.3 M to 1.3 M (-0.05 %) |
Mar 23 2010 | CBLI | CLEVELAND BIOLABS ... | Fonstein Michael | CEO, President | Sell | S | 3.56 | 300 | 1,068 | 1,275,900 | 1.3 M to 1.3 M (-0.02 %) |
Mar 17 2010 | CBLI | CLEVELAND BIOLABS ... | Gudkov Andrei V | Chief Scientific Of ... | Sell | S | 3.57 | 1,100 | 3,927 | 1,514,600 | 1.5 M to 1.5 M (-0.07 %) |
Mar 17 2010 | CBLI | CLEVELAND BIOLABS ... | Gudkov Andrei V | Chief Scientific Of ... | Sell | S | 3.58 | 50 | 179 | 1,515,700 | 1.5 M to 1.5 M (0.00 %) |
Mar 17 2010 | CBLI | CLEVELAND BIOLABS ... | Gudkov Andrei V | Chief Scientific Of ... | Sell | S | 3.59 | 650 | 2,334 | 1,515,750 | 1.5 M to 1.5 M (-0.04 %) |
Mar 17 2010 | CBLI | CLEVELAND BIOLABS ... | Gudkov Andrei V | Chief Scientific Of ... | Sell | S | 3.63 | 1,100 | 3,993 | 1,516,400 | 1.5 M to 1.5 M (-0.07 %) |
Mar 17 2010 | CBLI | CLEVELAND BIOLABS ... | Gudkov Andrei V | Chief Scientific Of ... | Sell | S | 3.60 | 500 | 1,800 | 1,517,500 | 1.5 M to 1.5 M (-0.03 %) |
Mar 17 2010 | CBLI | CLEVELAND BIOLABS ... | Gudkov Andrei V | Chief Scientific Of ... | Sell | S | 3.62 | 800 | 2,896 | 1,518,000 | 1.5 M to 1.5 M (-0.05 %) |
Mar 17 2010 | CBLI | CLEVELAND BIOLABS ... | Gudkov Andrei V | Chief Scientific Of ... | Sell | S | 3.64 | 500 | 1,820 | 1,518,800 | 1.5 M to 1.5 M (-0.03 %) |
Mar 17 2010 | CBLI | CLEVELAND BIOLABS ... | Gudkov Andrei V | Chief Scientific Of ... | Sell | S | 3.65 | 300 | 1,095 | 1,519,300 | 1.5 M to 1.5 M (-0.02 %) |
Mar 02 2010 | CBLI | CLEVELAND BIOLABS ... | Kogan Yakov | COO, Secretary | Sell | S | 3.78 | 900 | 3,402 | 673,200 | 674.1 K to 673.2 K (-0.13 %) |
Mar 02 2010 | CBLI | CLEVELAND BIOLABS ... | Kogan Yakov | COO, Secretary | Sell | S | 3.80 | 200 | 760 | 674,100 | 674.3 K to 674.1 K (-0.03 %) |
Mar 02 2010 | CBLI | CLEVELAND BIOLABS ... | Kogan Yakov | COO, Secretary | Sell | S | 3.82 | 200 | 764 | 674,300 | 674.5 K to 674.3 K (-0.03 %) |
Mar 02 2010 | CBLI | CLEVELAND BIOLABS ... | Kogan Yakov | COO, Secretary | Sell | S | 3.76 | 1,700 | 6,392 | 674,500 | 676.2 K to 674.5 K (-0.25 %) |
Mar 02 2010 | CBLI | CLEVELAND BIOLABS ... | Kogan Yakov | COO, Secretary | Sell | S | 3.90 | 500 | 1,950 | 676,200 | 676.7 K to 676.2 K (-0.07 %) |
Mar 02 2010 | CBLI | CLEVELAND BIOLABS ... | Kogan Yakov | COO, Secretary | Sell | S | 3.75 | 2,500 | 9,375 | 676,700 | 679.2 K to 676.7 K (-0.37 %) |
Feb 23 2010 | CBLI | CLEVELAND BIOLABS ... | Fonstein Michael | CEO, President | Sell | S | 3.90 | 1,900 | 7,410 | 1,276,200 | 1.3 M to 1.3 M (-0.15 %) |
Feb 23 2010 | CBLI | CLEVELAND BIOLABS ... | Fonstein Michael | CEO, President | Sell | S | 3.89 | 1,900 | 7,391 | 1,278,100 | 1.3 M to 1.3 M (-0.15 %) |
Feb 23 2010 | CBLI | CLEVELAND BIOLABS ... | Fonstein Michael | CEO, President | Sell | S | 3.88 | 200 | 776 | 1,280,000 | 1.3 M to 1.3 M (-0.02 %) |
Feb 23 2010 | CBLI | CLEVELAND BIOLABS ... | Fonstein Michael | CEO, President | Sell | S | 3.87 | 1,000 | 3,870 | 1,280,200 | 1.3 M to 1.3 M (-0.08 %) |
Feb 17 2010 | CBLI | CLEVELAND BIOLABS ... | Gudkov Andrei V | Chief Scientific Of ... | Sell | S | 3.85 | 700 | 2,695 | 1,519,600 | 1.5 M to 1.5 M (-0.05 %) |
Feb 17 2010 | CBLI | CLEVELAND BIOLABS ... | Gudkov Andrei V | Chief Scientific Of ... | Sell | S | 3.89 | 1,300 | 5,057 | 1,520,300 | 1.5 M to 1.5 M (-0.09 %) |
Feb 17 2010 | CBLI | CLEVELAND BIOLABS ... | Gudkov Andrei V | Chief Scientific Of ... | Sell | S | 3.92 | 100 | 392 | 1,521,600 | 1.5 M to 1.5 M (-0.01 %) |
Feb 17 2010 | CBLI | CLEVELAND BIOLABS ... | Gudkov Andrei V | Chief Scientific Of ... | Sell | S | 3.90 | 2,000 | 7,800 | 1,521,700 | 1.5 M to 1.5 M (-0.13 %) |
Feb 17 2010 | CBLI | CLEVELAND BIOLABS ... | Gudkov Andrei V | Chief Scientific Of ... | Sell | S | 3.86 | 100 | 386 | 1,523,700 | 1.5 M to 1.5 M (-0.01 %) |
Feb 17 2010 | CBLI | CLEVELAND BIOLABS ... | Gudkov Andrei V | Chief Scientific Of ... | Sell | S | 3.88 | 290 | 1,125 | 1,523,800 | 1.5 M to 1.5 M (-0.02 %) |
Feb 17 2010 | CBLI | CLEVELAND BIOLABS ... | Gudkov Andrei V | Chief Scientific Of ... | Sell | S | 3.91 | 300 | 1,173 | 1,524,090 | 1.5 M to 1.5 M (-0.02 %) |
Feb 17 2010 | CBLI | CLEVELAND BIOLABS ... | Gudkov Andrei V | Chief Scientific Of ... | Sell | S | 3.87 | 10 | 39 | 1,524,390 | 1.5 M to 1.5 M (0.00 %) |
Feb 17 2010 | CBLI | CLEVELAND BIOLABS ... | Gudkov Andrei V | Chief Scientific Of ... | Sell | S | 3.95 | 200 | 790 | 1,524,400 | 1.5 M to 1.5 M (-0.01 %) |
Feb 02 2010 | CBLI | CLEVELAND BIOLABS ... | Kogan Yakov | COO, Secretary | Sell | S | 3.95 | 5,000 | 19,750 | 679,200 | 684.2 K to 679.2 K (-0.73 %) |
Feb 02 2010 | CBLI | CLEVELAND BIOLABS ... | Kogan Yakov | COO, Secretary | Sell | S | 3.87 | 100 | 387 | 684,200 | 684.3 K to 684.2 K (-0.01 %) |
Feb 02 2010 | CBLI | CLEVELAND BIOLABS ... | Kogan Yakov | COO, Secretary | Sell | S | 3.88 | 400 | 1,552 | 684,300 | 684.7 K to 684.3 K (-0.06 %) |
Feb 02 2010 | CBLI | CLEVELAND BIOLABS ... | Kogan Yakov | COO, Secretary | Sell | S | 3.97 | 200 | 794 | 684,700 | 684.9 K to 684.7 K (-0.03 %) |
Feb 02 2010 | CBLI | CLEVELAND BIOLABS ... | Kogan Yakov | COO, Secretary | Sell | S | 3.96 | 300 | 1,188 | 684,900 | 685.2 K to 684.9 K (-0.04 %) |
Jan 25 2010 | CBLI | CLEVELAND BIOLABS ... | Fonstein Michael | CEO, President | Sell | S | 3.82 | 1,800 | 6,876 | 1,281,200 | 1.3 M to 1.3 M (-0.14 %) |
Jan 25 2010 | CBLI | CLEVELAND BIOLABS ... | Fonstein Michael | CEO, President | Sell | S | 3.81 | 1,300 | 4,953 | 1,283,000 | 1.3 M to 1.3 M (-0.10 %) |
Jan 25 2010 | CBLI | CLEVELAND BIOLABS ... | Fonstein Michael | CEO, President | Sell | S | 3.94 | 100 | 394 | 1,284,300 | 1.3 M to 1.3 M (-0.01 %) |
Jan 25 2010 | CBLI | CLEVELAND BIOLABS ... | Fonstein Michael | CEO, President | Sell | S | 3.92 | 1,200 | 4,704 | 1,284,400 | 1.3 M to 1.3 M (-0.09 %) |
Jan 25 2010 | CBLI | CLEVELAND BIOLABS ... | Fonstein Michael | CEO, President | Sell | S | 3.97 | 600 | 2,382 | 1,285,600 | 1.3 M to 1.3 M (-0.05 %) |
Jan 20 2010 | CBLI | CLEVELAND BIOLABS ... | Gudkov Andrei V | Chief Scientific Of ... | Sell | S | 3.85 | 700 | 2,695 | 1,524,600 | 1.5 M to 1.5 M (-0.05 %) |
Jan 20 2010 | CBLI | CLEVELAND BIOLABS ... | Gudkov Andrei V | Chief Scientific Of ... | Sell | S | 3.89 | 1,411 | 5,489 | 1,525,300 | 1.5 M to 1.5 M (-0.09 %) |
Jan 20 2010 | CBLI | CLEVELAND BIOLABS ... | Gudkov Andrei V | Chief Scientific Of ... | Sell | S | 3.88 | 1,500 | 5,820 | 1,526,711 | 1.5 M to 1.5 M (-0.10 %) |
Jan 20 2010 | CBLI | CLEVELAND BIOLABS ... | Gudkov Andrei V | Chief Scientific Of ... | Sell | S | 3.86 | 189 | 730 | 1,528,211 | 1.5 M to 1.5 M (-0.01 %) |
Jan 20 2010 | CBLI | CLEVELAND BIOLABS ... | Gudkov Andrei V | Chief Scientific Of ... | Sell | S | 3.91 | 300 | 1,173 | 1,528,400 | 1.5 M to 1.5 M (-0.02 %) |
Jan 20 2010 | CBLI | CLEVELAND BIOLABS ... | Gudkov Andrei V | Chief Scientific Of ... | Sell | S | 3.90 | 500 | 1,950 | 1,528,700 | 1.5 M to 1.5 M (-0.03 %) |
Jan 20 2010 | CBLI | CLEVELAND BIOLABS ... | Gudkov Andrei V | Chief Scientific Of ... | Sell | S | 3.87 | 400 | 1,548 | 1,529,200 | 1.5 M to 1.5 M (-0.03 %) |
Jan 04 2010 | CBLI | CLEVELAND BIOLABS ... | Kogan Yakov | COO, Secretary | Sell | S | 3.51 | 200 | 702 | 685,200 | 685.4 K to 685.2 K (-0.03 %) |
Jan 04 2010 | CBLI | CLEVELAND BIOLABS ... | Kogan Yakov | COO, Secretary | Sell | S | 3.50 | 5,800 | 20,300 | 685,400 | 691.2 K to 685.4 K (-0.84 %) |
Jan 04 2010 | CBLI | CLEVELAND BIOLABS ... | Gudkov Andrei V | Chief Scientific Of ... | Sell | S | 3.60 | 200 | 720 | 1,529,600 | 1.5 M to 1.5 M (-0.01 %) |
Jan 04 2010 | CBLI | CLEVELAND BIOLABS ... | Gudkov Andrei V | Chief Scientific Of ... | Sell | S | 3.55 | 751 | 2,666 | 1,529,800 | 1.5 M to 1.5 M (-0.05 %) |
Jan 04 2010 | CBLI | CLEVELAND BIOLABS ... | Fonstein Michael | CEO, President | Sell | S | 3.60 | 200 | 720 | 1,286,200 | 1.3 M to 1.3 M (-0.02 %) |
Jan 04 2010 | CBLI | CLEVELAND BIOLABS ... | Fonstein Michael | CEO, President | Sell | S | 3.55 | 751 | 2,666 | 1,286,400 | 1.3 M to 1.3 M (-0.06 %) |
Dec 28 2009 | CBLI | CLEVELAND BIOLABS ... | Gudkov Andrei V | Chief Scientific Of ... | Sell | S | 3.50 | 4,049 | 14,172 | 1,530,551 | 1.5 M to 1.5 M (-0.26 %) |
Dec 28 2009 | CBLI | CLEVELAND BIOLABS ... | Fonstein Michael | CEO, President | Sell | S | 3.50 | 4,049 | 14,172 | 1,287,151 | 1.3 M to 1.3 M (-0.31 %) |
Dec 02 2009 | CBLI | CLEVELAND BIOLABS ... | Kogan Yakov | COO, Secretary | Sell | S | 3.76 | 1,200 | 4,512 | 691,200 | 692.4 K to 691.2 K (-0.17 %) |
Dec 02 2009 | CBLI | CLEVELAND BIOLABS ... | Kogan Yakov | COO, Secretary | Sell | S | 3.75 | 4,800 | 18,000 | 692,400 | 697.2 K to 692.4 K (-0.69 %) |
Nov 23 2009 | CBLI | CLEVELAND BIOLABS ... | Fonstein Michael | CEO, President | Sell | S | 3.72 | 100 | 372 | 1,291,000 | 1.3 M to 1.3 M (-0.01 %) |
Nov 23 2009 | CBLI | CLEVELAND BIOLABS ... | Fonstein Michael | CEO, President | Sell | S | 3.66 | 100 | 366 | 1,291,100 | 1.3 M to 1.3 M (-0.01 %) |
Nov 23 2009 | CBLI | CLEVELAND BIOLABS ... | Fonstein Michael | CEO, President | Sell | S | 3.63 | 500 | 1,815 | 1,291,400 | 1.3 M to 1.3 M (-0.04 %) |
Nov 23 2009 | CBLI | CLEVELAND BIOLABS ... | Fonstein Michael | CEO, President | Sell | S | 3.62 | 1,800 | 6,516 | 1,291,900 | 1.3 M to 1.3 M (-0.14 %) |
Nov 23 2009 | CBLI | CLEVELAND BIOLABS ... | Fonstein Michael | CEO, President | Sell | S | 3.61 | 300 | 1,083 | 1,293,700 | 1.3 M to 1.3 M (-0.02 %) |
Nov 23 2009 | CBLI | CLEVELAND BIOLABS ... | Fonstein Michael | CEO, President | Sell | S | 3.60 | 1,100 | 3,960 | 1,294,000 | 1.3 M to 1.3 M (-0.08 %) |
Nov 23 2009 | CBLI | CLEVELAND BIOLABS ... | Fonstein Michael | CEO, President | Sell | S | 3.59 | 700 | 2,513 | 1,295,100 | 1.3 M to 1.3 M (-0.05 %) |
Nov 23 2009 | CBLI | CLEVELAND BIOLABS ... | Fonstein Michael | CEO, President | Sell | S | 3.57 | 400 | 1,428 | 1,295,800 | 1.3 M to 1.3 M (-0.03 %) |
Nov 17 2009 | CBLI | CLEVELAND BIOLABS ... | Gudkov Andrei V | Chief Scientific Of ... | Sell | S | 3.80 | 800 | 3,040 | 1,534,600 | 1.5 M to 1.5 M (-0.05 %) |
Nov 17 2009 | CBLI | CLEVELAND BIOLABS ... | Gudkov Andrei V | Chief Scientific Of ... | Sell | S | 3.82 | 300 | 1,146 | 1,535,400 | 1.5 M to 1.5 M (-0.02 %) |
Nov 17 2009 | CBLI | CLEVELAND BIOLABS ... | Gudkov Andrei V | Chief Scientific Of ... | Sell | S | 3.81 | 284 | 1,082 | 1,535,700 | 1.5 M to 1.5 M (-0.02 %) |
Nov 17 2009 | CBLI | CLEVELAND BIOLABS ... | Gudkov Andrei V | Chief Scientific Of ... | Sell | S | 3.78 | 400 | 1,512 | 1,535,984 | 1.5 M to 1.5 M (-0.03 %) |
Nov 17 2009 | CBLI | CLEVELAND BIOLABS ... | Gudkov Andrei V | Chief Scientific Of ... | Sell | S | 3.84 | 600 | 2,304 | 1,536,384 | 1.5 M to 1.5 M (-0.04 %) |
Nov 17 2009 | CBLI | CLEVELAND BIOLABS ... | Gudkov Andrei V | Chief Scientific Of ... | Sell | S | 3.86 | 916 | 3,536 | 1,536,984 | 1.5 M to 1.5 M (-0.06 %) |
Nov 17 2009 | CBLI | CLEVELAND BIOLABS ... | Gudkov Andrei V | Chief Scientific Of ... | Sell | S | 3.85 | 100 | 385 | 1,537,900 | 1.5 M to 1.5 M (-0.01 %) |
Nov 17 2009 | CBLI | CLEVELAND BIOLABS ... | Gudkov Andrei V | Chief Scientific Of ... | Sell | S | 3.91 | 1,100 | 4,301 | 1,538,000 | 1.5 M to 1.5 M (-0.07 %) |
Nov 17 2009 | CBLI | CLEVELAND BIOLABS ... | Gudkov Andrei V | Chief Scientific Of ... | Sell | S | 3.92 | 500 | 1,960 | 1,539,100 | 1.5 M to 1.5 M (-0.03 %) |
Nov 03 2009 | CBLI | CLEVELAND BIOLABS ... | Kogan Yakov | COO, Secretary | Sell | S | 3.88 | 1,300 | 5,044 | 697,200 | 698.5 K to 697.2 K (-0.19 %) |
Nov 03 2009 | CBLI | CLEVELAND BIOLABS ... | Kogan Yakov | COO, Secretary | Sell | S | 3.89 | 900 | 3,501 | 698,500 | 699.4 K to 698.5 K (-0.13 %) |
Nov 03 2009 | CBLI | CLEVELAND BIOLABS ... | Kogan Yakov | COO, Secretary | Sell | S | 3.91 | 500 | 1,955 | 699,400 | 699.9 K to 699.4 K (-0.07 %) |
Nov 03 2009 | CBLI | CLEVELAND BIOLABS ... | Kogan Yakov | COO, Secretary | Sell | S | 3.90 | 500 | 1,950 | 699,900 | 700.4 K to 699.9 K (-0.07 %) |
Nov 03 2009 | CBLI | CLEVELAND BIOLABS ... | Kogan Yakov | COO, Secretary | Sell | S | 3.93 | 300 | 1,179 | 700,400 | 700.7 K to 700.4 K (-0.04 %) |
Nov 03 2009 | CBLI | CLEVELAND BIOLABS ... | Kogan Yakov | COO, Secretary | Sell | S | 3.94 | 200 | 788 | 700,700 | 700.9 K to 700.7 K (-0.03 %) |
Nov 03 2009 | CBLI | CLEVELAND BIOLABS ... | Kogan Yakov | COO, Secretary | Sell | S | 3.99 | 100 | 399 | 700,900 | 701 K to 700.9 K (-0.01 %) |
Nov 03 2009 | CBLI | CLEVELAND BIOLABS ... | Kogan Yakov | COO, Secretary | Sell | S | 3.92 | 800 | 3,136 | 701,000 | 701.8 K to 701 K (-0.11 %) |
Nov 03 2009 | CBLI | CLEVELAND BIOLABS ... | Kogan Yakov | COO, Secretary | Sell | S | 3.84 | 100 | 384 | 701,800 | 701.9 K to 701.8 K (-0.01 %) |
Nov 03 2009 | CBLI | CLEVELAND BIOLABS ... | Kogan Yakov | COO, Secretary | Sell | S | 3.81 | 200 | 762 | 701,900 | 702.1 K to 701.9 K (-0.03 %) |
Nov 03 2009 | CBLI | CLEVELAND BIOLABS ... | Kogan Yakov | COO, Secretary | Sell | S | 3.80 | 500 | 1,900 | 702,100 | 702.6 K to 702.1 K (-0.07 %) |
Nov 03 2009 | CBLI | CLEVELAND BIOLABS ... | Kogan Yakov | COO, Secretary | Sell | S | 3.77 | 100 | 377 | 702,600 | 702.7 K to 702.6 K (-0.01 %) |
Nov 03 2009 | CBLI | CLEVELAND BIOLABS ... | Kogan Yakov | COO, Secretary | Sell | S | 3.76 | 100 | 376 | 702,700 | 702.8 K to 702.7 K (-0.01 %) |
Nov 03 2009 | CBLI | CLEVELAND BIOLABS ... | Kogan Yakov | COO, Secretary | Sell | S | 3.70 | 100 | 370 | 702,800 | 702.9 K to 702.8 K (-0.01 %) |
Nov 03 2009 | CBLI | CLEVELAND BIOLABS ... | Kogan Yakov | COO, Secretary | Sell | S | 3.69 | 200 | 738 | 702,900 | 703.1 K to 702.9 K (-0.03 %) |
Nov 03 2009 | CBLI | CLEVELAND BIOLABS ... | Kogan Yakov | COO, Secretary | Sell | S | 3.68 | 100 | 368 | 703,100 | 703.2 K to 703.1 K (-0.01 %) |
Oct 23 2009 | CBLI | CLEVELAND BIOLABS ... | Fonstein Michael | CEO, President | Sell | S | 4.16 | 1,441 | 5,995 | 1,296,200 | 1.3 M to 1.3 M (-0.11 %) |
Oct 23 2009 | CBLI | CLEVELAND BIOLABS ... | Fonstein Michael | CEO, President | Sell | S | 4.17 | 459 | 1,914 | 1,297,641 | 1.3 M to 1.3 M (-0.04 %) |
Oct 23 2009 | CBLI | CLEVELAND BIOLABS ... | Fonstein Michael | CEO, President | Sell | S | 4.20 | 1,400 | 5,880 | 1,298,100 | 1.3 M to 1.3 M (-0.11 %) |
Oct 23 2009 | CBLI | CLEVELAND BIOLABS ... | Fonstein Michael | CEO, President | Sell | S | 4.29 | 200 | 858 | 1,299,500 | 1.3 M to 1.3 M (-0.02 %) |
Oct 23 2009 | CBLI | CLEVELAND BIOLABS ... | Fonstein Michael | CEO, President | Sell | S | 4.21 | 600 | 2,526 | 1,299,700 | 1.3 M to 1.3 M (-0.05 %) |
Oct 23 2009 | CBLI | CLEVELAND BIOLABS ... | Fonstein Michael | CEO, President | Sell | S | 4.22 | 700 | 2,954 | 1,300,300 | 1.3 M to 1.3 M (-0.05 %) |
Oct 23 2009 | CBLI | CLEVELAND BIOLABS ... | Fonstein Michael | CEO, President | Sell | S | 4.23 | 200 | 846 | 1,301,000 | 1.3 M to 1.3 M (-0.02 %) |
Oct 19 2009 | CBLI | CLEVELAND BIOLABS ... | Gudkov Andrei V | Chief Scientific Of ... | Sell | S | 4.72 | 300 | 1,416 | 1,539,600 | 1.5 M to 1.5 M (-0.02 %) |
Oct 19 2009 | CBLI | CLEVELAND BIOLABS ... | Gudkov Andrei V | Chief Scientific Of ... | Sell | S | 4.76 | 4,600 | 21,896 | 1,539,900 | 1.5 M to 1.5 M (-0.30 %) |
Oct 19 2009 | CBLI | CLEVELAND BIOLABS ... | Gudkov Andrei V | Chief Scientific Of ... | Sell | S | 4.77 | 100 | 477 | 1,544,500 | 1.5 M to 1.5 M (-0.01 %) |
Oct 02 2009 | CBLI | CLEVELAND BIOLABS ... | Kogan Yakov | COO, Secretary | Sell | S | 4.13 | 500 | 2,065 | 703,200 | 703.7 K to 703.2 K (-0.07 %) |
Oct 02 2009 | CBLI | CLEVELAND BIOLABS ... | Kogan Yakov | COO, Secretary | Sell | S | 4.06 | 200 | 812 | 703,700 | 703.9 K to 703.7 K (-0.03 %) |
Oct 02 2009 | CBLI | CLEVELAND BIOLABS ... | Kogan Yakov | COO, Secretary | Sell | S | 4.05 | 1,500 | 6,075 | 703,900 | 705.4 K to 703.9 K (-0.21 %) |
Oct 02 2009 | CBLI | CLEVELAND BIOLABS ... | Kogan Yakov | COO, Secretary | Sell | S | 4.07 | 200 | 814 | 705,400 | 705.6 K to 705.4 K (-0.03 %) |
Oct 02 2009 | CBLI | CLEVELAND BIOLABS ... | Kogan Yakov | COO, Secretary | Sell | S | 4.12 | 300 | 1,236 | 705,600 | 705.9 K to 705.6 K (-0.04 %) |
Oct 02 2009 | CBLI | CLEVELAND BIOLABS ... | Kogan Yakov | COO, Secretary | Sell | S | 4.15 | 2,200 | 9,130 | 705,900 | 708.1 K to 705.9 K (-0.31 %) |
Oct 02 2009 | CBLI | CLEVELAND BIOLABS ... | Kogan Yakov | COO, Secretary | Sell | S | 4.16 | 200 | 832 | 708,100 | 708.3 K to 708.1 K (-0.03 %) |
Oct 02 2009 | CBLI | CLEVELAND BIOLABS ... | Kogan Yakov | COO, Secretary | Sell | S | 4.17 | 400 | 1,668 | 708,300 | 708.7 K to 708.3 K (-0.06 %) |
Oct 02 2009 | CBLI | CLEVELAND BIOLABS ... | Kogan Yakov | COO, Secretary | Sell | S | 4.02 | 500 | 2,010 | 708,700 | 709.2 K to 708.7 K (-0.07 %) |